Nutrien Ltd. NTR
72.23
(1.73)
(2.34%)
as of 25 Sep
- Market cap
- $35.4B
- P/E
- 14.6×
Follow NTR
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
12.74 | 15.34 | 13.22 | 15.78 |
+8 more quarters Free account |
P/S ratio |
1.07 | 1.30 | 1.12 | 1.07 | |
P/FCF ratio |
16.28 | 18.39 | 16.97 | 15.01 | |
P/Operating CF |
12.15 | (42.67) | 10.08 | (66.92) | |
P/B ratio |
1.16 | 1.44 | 1.18 | 1.13 | |
Price to Tangible BV |
2.47 | 3.19 | 2.60 | 2.52 | |
EV/Sales |
1.44 | 1.73 | 1.49 | 1.53 | |
EV/EBITDA |
6.50 | 7.68 | 6.56 | 7.27 | |
EV/Operating CF |
9.72 | 11.37 | 10.00 | 9.81 | |
EV/FCF |
21.93 | 24.39 | 22.64 | 21.46 | |
Quick Ratio |
0.83 | 0.53 | 0.58 | 0.81 | |
Current Ratio |
1.39 | 1.24 | 1.34 | 1.41 | |
Net Debt/EBITDA |
4.40 | 12.27 | 6.74 | 8.60 | |
Debt/Assets |
21.26% | 23.42% | 20.53% | 24.84% | |
Debt/Equity |
0.44 | 0.50 | 0.42 | 0.51 | |
Asset Turnover |
0.53 | 0.52 | 0.52 | 0.51 | |
Operating CF/Net income |
2.05 | (6.50) | 5.21 | (0.92) | |
Capex/Depreciation |
(0.81) | (0.54) | (1.32) | (0.86) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
10.44% | 17.85% | 19.04% | 16.10% | |
Intangible Assets out of Total Assets |
0.26 | 0.26 | 0.26 | 0.27 | |
Share Based Compensation of Revenue |
(0.38%) | 1.92% | 0.82% | 0.47% | |
Graham Net Nets |
(0.38) | (0.34) | (0.41) | (0.43) | |
Graham Number |
77.53 | 76.12 | 74.03 | 65.85 | |
Earnings Yield |
7.85% | 6.52% | 7.57% | 6.34% | |
Free Cash Flow Yield |
6.14% | 5.44% | 5.89% | 6.66% | |
Revenue per Share |
22.54 | 12.56 | 10.98 | 12.37 | |
Operating CF per Share |
5.18 | (1.77) | 6.12 | (0.88) | |
Capex per Share |
(1.02) | (0.68) | (1.54) | (1.09) | |
Free Cash Flow per Share |
4.16 | (2.44) | 4.58 | (1.97) | |
Cash per Share |
1.92 | 1.61 | 1.44 | 1.29 | |
Shareholders Equity per Share |
54.08 | 52.35 | 52.16 | 51.80 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
54.08 | 52.35 | 52.16 | 51.80 | |
Free Cash Flow |
1,993.00 | (1,176.00) | 2,226.00 | (956.00) | |
Working Capital |
4,544.00 | 3,174.00 | 3,708.00 | 4,201.00 | |
Capital Expenditures |
(491.00) | (325.00) | (751.00) | (530.00) | |
Net Current Asset Value |
(11,450.00) | (12,256.00) | (12,187.00) | (12,199.00) | |
EV/EBIT |
10.52 | 12.45 | 10.72 | 12.69 | |
Capex to Sales |
0.05 | 0.05 | 0.14 | 0.09 | |
Net Profit Margin |
11.23% | 2.17% | 10.69% | 7.72% | |
Price to Operating Income |
7.81 | 9.38 | 8.03 | 8.88 | |
| Other line items | |||||
Average Receivables |
8,386.50 | 5,948.00 | 5,532.50 | 7,736.50 | |
Average Payables |
9,024.00 | 9,127.50 | 7,961.00 | — | |
Average Inventory |
5,870.00 | 8,336.50 | 6,562.50 | 5,085.50 | |
Average Assets |
53,405.00 | 53,496.00 | 52,070.50 | 51,868.50 | |
Average Common Equity |
25,529.00 | 24,631.00 | 24,903.50 | 25,079.50 |
Columns are period end dates